The OncoDaily – Seismic Shift: Innovations in MRD Testing and Pathology webinar will take place on November 6, 2026, online via X (OncoDaily).

Organized by OncoDaily in partnership with Natera, the session will explore recent advances in Molecular Residual Disease (MRD) testing, including multimodal testing, personalized circulating tumor DNA (ctDNA) technology, dynamic biomarker tracking, and evolving pathology workflows.

The webinar will examine how modern MRD methodologies are improving analytical sensitivity, specificity, turnaround times, and clinical monitoring across solid and hematologic malignancies. The session will also address practical approaches to optimizing tissue stewardship, specimen logistics, and standardized reporting to support reliable and actionable results.